156 related articles for article (PubMed ID: 26415609)
21. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma.
Wang N; Tesfaluul N; Li J; Gao X; Liu S; Yue B
Ann Hematol; 2019 Dec; 98(12):2769-2780. PubMed ID: 31748925
[TBL] [Abstract][Full Text] [Related]
22. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
23. Detection methods of circulating tumor cells in cutaneous melanoma: a systematic review.
Rodic S; Mihalcioiu C; Saleh RR
Crit Rev Oncol Hematol; 2014 Jul; 91(1):74-92. PubMed ID: 24530125
[TBL] [Abstract][Full Text] [Related]
24. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.
Mumford BS; Robertson GP
Mol Diagn Ther; 2014 Apr; 18(2):175-83. PubMed ID: 24297151
[TBL] [Abstract][Full Text] [Related]
25. Capture and Isolation of Circulating Melanoma Cells Using Photoacoustic Flowmetry.
Edgar RH; Cook J; Douglas M; Samson AP; Viator JA
Methods Mol Biol; 2021; 2265():203-212. PubMed ID: 33704716
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
27. S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells.
Cayrefourcq L; De Roeck A; Garcia C; Stoebner PE; Fichel F; Garima F; Perriard F; Daures JP; Meunier L; Alix-Panabières C
Cells; 2019 Jul; 8(7):. PubMed ID: 31330795
[TBL] [Abstract][Full Text] [Related]
28. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
29. Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles.
Aya-Bonilla C; Gray ES; Manikandan J; Freeman JB; Zaenker P; Reid AL; Khattak MA; Frank MH; Millward M; Ziman M
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30769764
[TBL] [Abstract][Full Text] [Related]
30. Identification of circulating melanoma cells in uveal melanoma patients by dual-marker immunoenrichment.
Tura A; Lüke J; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4395-404. PubMed ID: 24970258
[TBL] [Abstract][Full Text] [Related]
31. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
34. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.
Guo Q; Grimmig T; Gonzalez G; Giobbie-Hurder A; Berg G; Carr N; Wilson BJ; Banerjee P; Ma J; Gold JS; Nandi B; Huang Q; Waaga-Gasser AM; Lian CG; Murphy GF; Frank MH; Gasser M; Frank NY
J Biol Chem; 2018 Jul; 293(28):11166-11178. PubMed ID: 29789423
[TBL] [Abstract][Full Text] [Related]
35. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
36. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.
Ulmer A; Schmidt-Kittler O; Fischer J; Ellwanger U; Rassner G; Riethmüller G; Fierlbeck G; Klein CA
Clin Cancer Res; 2004 Jan; 10(2):531-7. PubMed ID: 14760074
[TBL] [Abstract][Full Text] [Related]
37. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
[TBL] [Abstract][Full Text] [Related]
38. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
[TBL] [Abstract][Full Text] [Related]
39. ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.
Louphrasitthiphol P; Chauhan J; Goding CR
Pigment Cell Melanoma Res; 2020 Jan; 33(1):112-118. PubMed ID: 31595650
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
